NASDAQ:ARPO
Delisted
Aerpio Pharmaceuticals Inc. Stock News
$13.14
-0.370 (-2.74%)
At Close: Aug 17, 2022
Spreading ‘Biden fever’: John Phillips
02:04am, Thursday, 30'th Jul 2020
If the Progressive Turnout Project wants Democrats to turn out, they’re going to have to rely on “Biden Fever.”
The Daily Biotech Pulse: Mixed Tidings From Novavax, Radius Health Out-licenses Breast Cancer Drug, 3 IPOs
12:00am, Friday, 24'th Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 23)
Abbott Laboratories (NYSE: ABT)
ABIOMED, Inc. (NASDAQ: ABMD)
Acceleron Pharma Inc (NASDAQ: XLRN)
Aerpio...
Outlook of Diabetic Macular Edema (DME) 2020-2025 - Current Landscape and the Way Forward - ResearchAndMarkets.com
12:00am, Monday, 13'th Jul 2020
The
Fitch revises Geo Energy's rating back to CC after failed bond tender offer
08:24am, Thursday, 02'nd Jul 2020
FITCH Ratings has revised Indonesian coal miner Geo Energy Energy Resources' long-term issuer default rating to CC from C. Read more at The Business Times.
2020 Study into the Global Macular Edema Industry - Market Size and Drug Sales - ResearchAndMarkets.com
12:00am, Thursday, 02'nd Jul 2020
The
Aerpio Pharmaceuticals, Inc. (ARPO) Outpaces Stock Market Gains: What You Should Know
09:50pm, Monday, 29'th Jun 2020
In the latest trading session, Aerpio Pharmaceuticals, Inc. (ARPO) closed at $1.26, marking a +1.61% move from the previous day.
Is Aerpio Pharmaceuticals (ARPO) Outperforming Other Medical Stocks This Year?
03:30pm, Monday, 29'th Jun 2020
Is (ARPO) Outperforming Other Medical Stocks This Year?
Mystery of deep war shelter buried beneath college in Plymouth
04:00am, Saturday, 27'th Jun 2020
There were hundreds of air raid shelters in Plymouth - but only one was listed as 'deep'
Aerpio Announces Initiation of 28-Day Phase 2 Razuprotafib Glaucoma Trial
12:00pm, Wednesday, 24'th Jun 2020
Aerpio Pharmaceuticals, Inc. (“Aerpio”) (ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases, ARDS associated with COVID-19, and diabetic
Aerpio Pharmaceuticals' Shares March Higher, Can It Continue?
11:24am, Monday, 22'nd Jun 2020
As of late, it has definitely been a great time to be an investor in Aerpio Pharmaceuticals.
Aerpio Pharmaceuticals, Inc. (ARPO) Gains As Market Dips: What You Should Know
09:45pm, Friday, 19'th Jun 2020
Aerpio Pharmaceuticals, Inc. (ARPO) closed the most recent trading day at $1.25, moving +0.81% from the previous trading session.
Top Ranked Momentum Stocks to Buy for June 19th
04:37pm, Friday, 19'th Jun 2020
Top Ranked Momentum Stocks to Buy for June 19th
Emprunt: l'AKB lève 100 millions de francs à 0,01%, échéance 2028 | Zone bourse
08:35am, Friday, 19'th Jun 2020New Strong Buy Stocks For June 15th
02:07pm, Monday, 15'th Jun 2020
New Strong Buy Stocks For June 15th
